Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

The Nice Manifesto

27.03.2006


Almost 5,000 delegates at the 5th European Breast Cancer Conference (EBCC-5) today attended the presentation of the Nice Manifesto. The manifesto represents a commitment from doctors, nurses, patients and advocates to support breast cancer research and improve patient care. Breast Cancer is the most common cancer in European women and although survival rates are improving there is still a long way to go.



The manifesto is endorsed by the three organisations – Europa Donna – The European Breast Cancer Coalition, The European Organisation for Research and Treatment of Cancer (EORTC) and the European Society of Mastology (EUSOMA) who hosted the event. This conference is the only one of its kind as it represents the views of all the major breast cancer advocacy groups and institutions in one arena. This manifesto is a unique document that represents the concerns of all those involved in breast cancer treatment, from the patient to the oncologist.

Dr A. Costa, the chair of the European Breast Cancer Conference, and Dr S. Kyriakides, co-chair stated, “Europe is now 500 million strong, more than half of these are women, and at least one in ten will experience breast cancer. This is a major public health priority. The Nice manifesto is a promise to improve breast cancer care for all those patients across Europe. It is a basic right for patients to expect the best care and the conference pledges to meet the challenge.”


The following seven goals form the basis of the manifesto:

1. Improve the number and quality of European screening programmes
Population based screening programmes carried out in accordance with EU guidelines for quality assurance in mammography screening help to detect early breast cancer and save lives. Increasing the number of screening programmes free at the point of access and improving their quality would save the lives of many European women. Women should be encouraged to participate in screening programmes.

2. Support breast cancer research
Independent academic research is under threat due to insufficient funding in many European countries. It is a driving force in improving our knowledge of cancer and developing tailored, potentially cost-saving therapies. Studies which answer important clinical questions and which have the potential to increase our knowledge of the biological and genetic basis of the disease should be given priority.

3. Rethink the breast cancer staging system
Researchers and clinicians should be creative in designing new quality assured diagnostic and staging systems which improve prediction of outcome. The genetic makeup of the tumour, for instance, should be defined in greater detail to identify the natural history of the disease in each individual patient, and the likelihood of response to standard therapies and molecular targeted treatments.

4. Define metastatic breast cancer guidelines
Most women still die from metastatic breast cancer. The general criteria on how to manage metastatic breast cancer need to be defined. Specific guidelines can help the patient and the clinician make the right choice.

5. Increase the number of breast care nurses
In most European countries today there are no breast care nurses. Breast care nurses can improve the treatment and management of breast cancer for patients. Greater involvement will improve patient care and quality of life.

6. Expand the Breast Unit accreditation process
Breast units should be accredited to ensure that they meet guideline requirements for standardisation of best care. Accreditation guidelines for carrying this out should be developed not only by professionals, but also by patient advocacy groups. Women should have equity of access and the choice to select appropriate facilities for diagnosis and treatment and be sure they are getting gold standard.

7. Give recognition to the essential role played by charities in independent breast cancer research
Encourage those charities to realise the potential benefits of their effort for all European patients and to expand their work even further.

EBCC-5 Press Office | alfa
Further information:
http://www.fecs.be/emc.asp?pageId=611&Type=P

More articles from Health and Medicine:

nachricht Collagen nanofibrils in mammalian tissues get stronger with exercise
14.12.2018 | University of Illinois College of Engineering

nachricht New discoveries predict ability to forecast dementia from single molecule
12.12.2018 | UT Southwestern Medical Center

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Data use draining your battery? Tiny device to speed up memory while also saving power

The more objects we make "smart," from watches to entire buildings, the greater the need for these devices to store and retrieve massive amounts of data quickly without consuming too much power.

Millions of new memory cells could be part of a computer chip and provide that speed and energy savings, thanks to the discovery of a previously unobserved...

Im Focus: An energy-efficient way to stay warm: Sew high-tech heating patches to your clothes

Personal patches could reduce energy waste in buildings, Rutgers-led study says

What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...

Im Focus: Lethal combination: Drug cocktail turns off the juice to cancer cells

A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.

The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...

Im Focus: New Foldable Drone Flies through Narrow Holes in Rescue Missions

A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.

Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...

Im Focus: Topological material switched off and on for the first time

Key advance for future topological transistors

Over the last decade, there has been much excitement about the discovery, recognised by the Nobel Prize in Physics only two years ago, that there are two types...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

ICTM Conference 2019: Digitization emerges as an engineering trend for turbomachinery construction

12.12.2018 | Event News

New Plastics Economy Investor Forum - Meeting Point for Innovations

10.12.2018 | Event News

EGU 2019 meeting: Media registration now open

06.12.2018 | Event News

 
Latest News

Data use draining your battery? Tiny device to speed up memory while also saving power

14.12.2018 | Power and Electrical Engineering

Tangled magnetic fields power cosmic particle accelerators

14.12.2018 | Physics and Astronomy

In search of missing worlds, Hubble finds a fast evaporating exoplanet

14.12.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>